Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Alan K Jacobs"'
Autor:
Annette F. Okai, Lilyana Amezcua, Regina R. Berkovich, Angel R. Chinea, Keith R. Edwards, Brian Steingo, Aljoeson Walker, Alan K. Jacobs, Nadia Daizadeh, Mitzi J. Williams, the CARE-MS I, CARE-MS II, CAMMS03409, and TOPAZ Investigators
Publikováno v:
Neurology and Therapy, Vol 8, Iss 2, Pp 367-381 (2019)
Abstract Introduction Multiple sclerosis (MS) patients of African descent have increased risk for disease progression and may be less responsive to disease-modifying therapy. Methods Patients in the CARE-MS studies received alemtuzumab 12 mg/day [ini
Externí odkaz:
https://doaj.org/article/3c88f76d51334febbab539a6097228c0
Publikováno v:
Annals of emergency medicine. 21(2)
We report an unusual cause of unresponsiveness in a 73-year-old woman seen in the emergency department. Extensive evaluation, including an emergency EEG that demonstrated rhythmic, high-voltage spike-and-wave discharges characteristic of convulsive a
Publikováno v:
Headache. 31(4)
Two cases of headache during pregnancy were associated with MRI findings suggestive of venous sinus thrombosis. The findings, however, were atypical, and of uncertain clinical significance. Venous sinus thrombosis typically does not occur during the
Publikováno v:
Journal of Neuropathology and Experimental Neurology. 45:377
Autor:
Okai, Annette F.1 (AUTHOR) afokai@gmail.com, Amezcua, Lilyana2 (AUTHOR), Berkovich, Regina R.2,3 (AUTHOR), Chinea, Angel R.4 (AUTHOR), Edwards, Keith R.5 (AUTHOR), Steingo, Brian6 (AUTHOR), Walker, Aljoeson7 (AUTHOR), Jacobs, Alan K.8 (AUTHOR), Daizadeh, Nadia8 (AUTHOR), Williams, Mitzi J.9 (AUTHOR)
Publikováno v:
Neurology & Therapy. Dec2019, Vol. 8 Issue 2, p367-381. 15p.
Autor:
Horáková, Dana, Boster, Aaron, Bertolotto, Antonio, Freedman, Mark S, Firmino*, Isabel, Cavalier, Steven J, Jacobs*, Alan K, Thangavelu*, Karthinathan, Daizadeh, Nadia, Poole*, Elizabeth M, Baker, Darren P, Margolin*, David H, Ziemssen, Tjalf
Publikováno v:
Multiple Sclerosis Journal - Experimental, Translational & Clinical; 12/18/2020, p1-10, 10p
Autor:
Wiendl, Heinz, Carraro, Matthew, Comi, Giancarlo, Izquierdo, Guillermo, Ho Jin Kim, Sharrack, Basil, Tornatore, Carlo, Daizadeh, Nadia, Chung, Luke, Jacobs, Alan K., Hogan, Richard J., Wychowski, Linda V., Van Wijmeersch, Bart
Publikováno v:
Neurology® Neuroimmunology & Neuroinflammation; Jan2020, Vol. 7 Issue 1, p1-10, 10p
Publikováno v:
Multiple Sclerosis (13524585); Oct2005, Vol. 11 Issue 5, p585-591, 7p
Publikováno v:
Headache: The Journal of Head & Face Pain; Nov/Dec2004, Vol. 44 Issue 10, p969-977, 9p
Autor:
Horáková, Dana, Boster, Aaron, Bertolotto, Antonio, Freedman, Mark S, Firmino*, Isabel, Cavalier, Steven J, Jacobs*, Alan K, Karthinathan Thangavelu, Daizadeh, Nadia, Poole*, Elizabeth M, Baker, Darren P, Margolin*, David H, Tjalf Ziemssen
Supplemental material, sj-pdf-1-mso-10.1177_2055217320972137 for Proportion of alemtuzumab-treated patients converting from relapsing-remitting multiple sclerosis to secondary progressive multiple sclerosis over 6 years by Dana Horáková, Aaron Bost
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b092ead60e9eae90b2a9f4b9fa69c8f